NRF2 is highly expressed in PDAC [68]; its inhibition was shown to sensitize PDAC cells to apoptosis [69] and synergized with cytotoxic therapy to cause cell death in cancer cells across various entities [70,71,72,73]. This evidence concerns the gene NFE2L2 and cancer.